DE3782590D1 - Methode fuer selektiven zuwachs des anteils der gewoehnlichen hauptkomponente des antibiotischen komplexes a 40926. - Google Patents

Methode fuer selektiven zuwachs des anteils der gewoehnlichen hauptkomponente des antibiotischen komplexes a 40926.

Info

Publication number
DE3782590D1
DE3782590D1 DE8787112862T DE3782590T DE3782590D1 DE 3782590 D1 DE3782590 D1 DE 3782590D1 DE 8787112862 T DE8787112862 T DE 8787112862T DE 3782590 T DE3782590 T DE 3782590T DE 3782590 D1 DE3782590 D1 DE 3782590D1
Authority
DE
Germany
Prior art keywords
proportion
main component
common main
antibiotic complex
selective increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787112862T
Other languages
English (en)
Other versions
DE3782590T2 (de
Inventor
Enrico Selva
Maurizio Denaro
Luciano Gastaldo
Giovanni Cassani
Francesco Parenti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicuron Pharmaceuticals LLC
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of DE3782590D1 publication Critical patent/DE3782590D1/de
Application granted granted Critical
Publication of DE3782590T2 publication Critical patent/DE3782590T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicon Polymers (AREA)
DE8787112862T 1986-09-11 1987-09-03 Methode fuer selektiven zuwachs des anteils der gewoehnlichen hauptkomponente des antibiotischen komplexes a 40926. Expired - Lifetime DE3782590T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868621912A GB8621912D0 (en) 1986-09-11 1986-09-11 Increasing ratio of components of anti-biotic complex

Publications (2)

Publication Number Publication Date
DE3782590D1 true DE3782590D1 (de) 1992-12-17
DE3782590T2 DE3782590T2 (de) 1993-03-25

Family

ID=10604036

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787112862T Expired - Lifetime DE3782590T2 (de) 1986-09-11 1987-09-03 Methode fuer selektiven zuwachs des anteils der gewoehnlichen hauptkomponente des antibiotischen komplexes a 40926.

Country Status (15)

Country Link
US (1) US5843679A (de)
EP (1) EP0259781B1 (de)
JP (1) JP2520139B2 (de)
KR (1) KR960013575B1 (de)
AT (1) ATE82328T1 (de)
CA (1) CA1297055C (de)
DE (1) DE3782590T2 (de)
DK (1) DK165375C (de)
ES (1) ES2052531T3 (de)
GB (1) GB8621912D0 (de)
GR (1) GR3006262T3 (de)
HU (1) HU197771B (de)
IE (1) IE60419B1 (de)
IL (1) IL83735A (de)
ZA (1) ZA876774B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
ES2224173T3 (es) * 1995-07-05 2005-03-01 Aventis Bulk S.P.A. Purificacion de antibioticos dalbaheptidos por enfoque isoelectrico.
EP1213298A1 (de) * 2000-12-04 2002-06-12 Biosearch Italia S.p.A. Antibiotika GE 23077, ihre pharmazeutisch-akzeptablen Salze und Zubereitungen, sowie ihre Verwendung
EP1413626A1 (de) * 2002-10-23 2004-04-28 Vicuron Pharmaceuticals, Inc. Gene und Proteine für die Biosyntese von dem glycopeptidischen Antibiotikum A40926
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20050130909A1 (en) * 2002-11-18 2005-06-16 Luigi Colombo Dalbavancin compositions for treatment of bacterial infections
CN101851277B (zh) * 2009-03-12 2012-10-03 成都雅途生物技术有限公司 一种道古霉素关键中间体a40926 bo组分的纯化制备方法
CN110183519B (zh) * 2019-05-06 2023-04-11 大邦(湖南)生物制药有限公司 一种达巴万星关键中间体a40926的分离纯化方法
CN112480214B (zh) * 2020-12-14 2023-03-28 成都雅途生物技术有限公司 一种达巴万星关键中间体a40926的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8420405D0 (en) * 1984-08-10 1984-09-12 Lepetit Spa Preparing antibiotic l 17046
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex
NL8403377A (nl) * 1984-11-06 1986-06-02 Schuitemaker Mach Bv Opraaploswagen.
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
GB8531846D0 (en) * 1985-12-30 1986-02-05 Lepetit Spa Antibiotic a 40926 mannosyl aglycon
GB8608798D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Recovery of glycopeptide antibiotics from aqueous solutions
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
GR871488B (en) * 1986-10-10 1987-11-12 Lepetit Spa New antibiotics
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
ES2084595T3 (es) * 1988-12-27 1996-05-16 Lepetit Spa Procedimiento quimico mejorado para preparar el antibiotico l/17392 (desglucoteicoplanina) y sus sales.
DK0479086T3 (da) * 1990-10-01 1995-10-23 Lepetit Spa Fremgangsmåde til indvinding af teicoplanin
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives

Also Published As

Publication number Publication date
IE872420L (en) 1988-03-11
KR880004095A (ko) 1988-06-01
IL83735A0 (en) 1988-02-29
ZA876774B (en) 1988-06-29
HUT46744A (en) 1988-11-28
DK461887D0 (da) 1987-09-04
GR3006262T3 (de) 1993-06-21
US5843679A (en) 1998-12-01
IE60419B1 (en) 1994-07-13
EP0259781B1 (de) 1992-11-11
JPS6377892A (ja) 1988-04-08
HU197771B (en) 1989-05-29
EP0259781A3 (en) 1990-05-02
EP0259781A2 (de) 1988-03-16
DK461887A (da) 1988-03-12
JP2520139B2 (ja) 1996-07-31
IL83735A (en) 1992-02-16
CA1297055C (en) 1992-03-10
DE3782590T2 (de) 1993-03-25
GB8621912D0 (en) 1986-10-15
ATE82328T1 (de) 1992-11-15
DK165375C (da) 1993-04-05
DK165375B (da) 1992-11-16
KR960013575B1 (ko) 1996-10-09
ES2052531T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
ATE87335T1 (de) Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.
IE840493L (en) Biosynthetically produced human nerve growth factor.
IL84285A0 (en) Polynucleotide molecule,chimeric antibody with specificity to human tumor antigen,process for the preparation thereof and methods utilizing the same
DE3882242T2 (de) Fermentationsverfahren zur Herstellung von 2-Keto-L-Gulonsäuren.
FI874082A0 (fi) Menetelmä glykopeptidiantibioottien valmistamiseksi ja niitä tuottavia mikro-organismiviljelmiä
DE3888393D1 (de) BICMOS-Verfahren zur Herstellung selbstausrichtender NPN-Emitter und -Basen sowie MOSFET-Sources und -Drains.
ATE132904T1 (de) Verfahren zur herstellung von trehalulose und isomaltulose
DE3688336T2 (de) Verfahren zur Herstellung von organischen Säuren unter Verwendung von Mikroorganismen.
DE3782590T2 (de) Methode fuer selektiven zuwachs des anteils der gewoehnlichen hauptkomponente des antibiotischen komplexes a 40926.
ATE95836T1 (de) Zum abbau von glycosaminoglycan faehige enzymzusammensetzung und verfahren zur herstellung dieser zusammensetzung.
DE3876769D1 (de) Mikrobiologische herstellung von 9-alpha-hydroxy-17-keto-steroiden.
DE3782169D1 (de) Verfahren zur herstellung von antibiotica 10381b.
DE3884741T2 (de) Mikrobiologisches Verfahren zur Herstellung von UK-61.689 und Mikroorganismen zur Verwendung darin.
DE3480216D1 (en) Process for producing arphamenine in high yield
ATE69268T1 (de) Verfahren zur herstellung von 4-androsten-3, 17- dion und 1,4-androstadien-3,17-dion.
ATE91507T1 (de) Fermentationsverfahren zur herstellung von 2-keto-l-gulonsaeuren.
ATE67480T1 (de) Verfahren zur herstellung von 5-hydroxydiprafenon und seiner salze mit saeuren.
ATE70835T1 (de) Verfahren zur herstellung von alpha-tocopherol und zwischenprodukte fuer dieses verfahren.
ATE83506T1 (de) Mikrobiologische herstellung von 9-alpha-hydroxy- 17-keto-steroiden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOSEARCH ITALIA S.P.A., GERENZANO, IT

8327 Change in the person/name/address of the patent owner

Owner name: VICURON PHARMACEUTTICALS INC.(N.D.GES.STAATES DELA

8328 Change in the person/name/address of the agent

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN